# Omeros Corporation

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/omeros-corporation/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Seattle, United States |
| OpenAlex ID | https://openalex.org/F4320319050 |
| ROR ID | https://ror.org/01r5k6556 |
| Works | 500 |

## Funder papers

- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [The pathogenesis of IgA nephropathy and implications for treatment](https://scholariq.org/papers/the-pathogenesis-of-iga-nephropathy-and-implications-for-treatment/)
- [Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis](https://scholariq.org/papers/executive-summary-of-the-kdigo-2024-clinical-practice-guideline-for-the-2/)
- [Health Care Resource Utilization and Productivity Impairment in Adults with Immunoglobulin A Nephropathy: A Real-World, Observational, Global Analysis](https://scholariq.org/papers/health-care-resource-utilization-and-productivity-impairment-in-adults-with/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.